The NHS is revolutionising cancer treatment. Let’s back its mission | Iain Foulkes

Biotherapeutics are a great leap forward. Now proper funding is needed to fulfil their potential

Theresa May's announcement this week of a renewed NHS focus on diagnosing cancers earlier was warmly welcomed here at Cancer Research UK. Early detection and diagnosis is a key priority for us. A clear government ambition that within a decade 75% of cancer patients should be diagnosed at an early stage, when they still have options that can cure, would be great progress from where we are today.

But should this ambition be realised, all patients still need treating - and, unfortunately, cancer can often evolve a stubborn resistance to the best therapies we currently have.